Previous Page  12 / 15 Next Page
Information
Show Menu
Previous Page 12 / 15 Next Page
Page Background

HSP en PLS

10

Literatuurlijst

1.

Anderson A, Tulchin-Francis K, Smith L, Delgado M. Gait outcomes and energy efficiency in patients with hereditary

spastic paraplegia. Develop Med Child Neurol 2015;57(S5):70–71.

2.

Andrews J, Paganoni S, Braastad C, Cudkowicz M, Atassi N. Disease burden in upper motor neuron syndromes: a survey of

patient perspectives. J Clin Neuromuscul Dis 2014;16:104–105.

3.

De Bot S, Scheffer H, Schelhaas H, Knoers N, Willemsen M, van denWarrenburg B, et al. Hereditaire spastische

paraparesen: stand van zaken en leidraad voor genetisch onderzoek. Tijdschr Neurol Neurochir 2009;110:215-228.

4.

Brugman F, Wokke J. Primary lateral sclerosis. Orphanet Encyclopedia, 2004.

5.

Bruyn R, Frants R. Van gen naar ziekte; spastine en hereditaire spastische paraparese. Ned Tijdschr Geneeskd

2004;148:179-181.

6.

Fink J. Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol

2013;126:307–328.

7.

Floeter M, Mills R. Progression in primary lateral sclerosis: a prospective analysis. Amyotroph Lateral Scler 2009;10:339-46.

8.

Hendriks S. Generieke zorgthema Huisartsgeneeskundige zorg. 2014.

www.zorgstandaarden.net/nl/wat-is-een-

zeldzame-aandoening/generieke-zorgthemas.

9.

Kuipers-Upmeijer J, de Jager A, Hew J, Snoek J, vanWeerden T. Primary lateral sclerosis: clinical, neurophysiological, and

magnetic resonance findings. J Neurol Neurosurg Psychiatry 2001;71:615-620.

10. Nonnekes J. Proefschrift: Balance and gait in neurodegenerative disease: what startle tells us about motor control. 2015.

11. Peters T, Floeter M. Usage of support services in primary lateral sclerosis. Amyotroph Lateral Scler 2009;10:185-187.

12. Royal College of Physicians, British Society of Rehabilitation Medicine, Chartered Society of Physiotherapy, Association of

Chartered Physiotherapists Interested in Neurology. Spasticity in adults: management using botulinum toxin. National

guidelines. London: RCP, 2009.

13. Ruano L, Melo C, Carolina Silva M, Coutinho P. The global epidemiology of hereditary ataxia and spastic paraplegia: a

systematic review of prevalence studies. Neuroepidemiol 2014;42:174–183.

14. Spierziekten Nederland. Folder K048: Hereditaire spastische paraparese.

15. Spierziekten Nederland. Folder K049: (Primaire) laterale sclerose.

16. Spierziekten Nederland. Brochure D017: ‘HSP en PLS – Diagnose en behandeling’.

17. Spierziekten Nederland. Brochure D017A: ‘HSP en PLS – Omgaan met de ziekte’.

18. Tesson C, Koht J, Stevanin G. Delving into the complexity of hereditary spastic paraplegias: how unexpected phenotypes

and inheritance modes are revolutionizing their nosology. HumGenet 2015;134:511–538.

19. Vajda I. Visiedocument Concentratie en organisatie van zorg bij zeldzame aandoeningen. 2015. www.zorgstandaarden.

net/zza/media/upload/pages/file/Visiedocument/Visiedocument-Concentratie-en-Organisatie-mei-2015.pdf.